November 27, 2025 - 19:27

In a significant move to enhance the integration of artificial intelligence in the manufacturing sector, the UK government has appointed the Chief Technology Officer of the High Value Manufacturing (HVM) Catapult as the national AI champion. This initiative aims to accelerate the adoption of AI technologies across the UK manufacturing landscape, which is poised to benefit from increased efficiency, productivity, and innovation.
The newly appointed AI champion will be tasked with spearheading efforts to facilitate the implementation of AI solutions in manufacturing processes. This includes working closely with industry leaders and stakeholders to identify key areas where AI can make the most impact. The government envisions that by harnessing the power of AI, UK manufacturers can not only improve their operational capabilities but also enhance their competitiveness on a global scale.
As the manufacturing sector adapts to the challenges of the modern economy, the role of AI is becoming increasingly critical. This appointment signals a commitment to ensuring that the UK remains at the forefront of technological advancements in manufacturing.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...